Companies similar to CO-D THERAPEUTICS
Sign up to Download

1-30 of 6,777,510 results

  • co-drx.com
  • 1
  • 6
Co-D Therapeutics' mission is to aggressively develop its lead product Triolimus to treat multiple types of cancer. We seek to position Co-D as a leader in the evolving field of nano-medicine drug combinations for cancer treatment... Co-D..
Relevance: 30.699276
  • www.genchemchina.com
  • 5
  • 2
GenChem & GenPharm (Changzhou) Co.,Ltd., formerly Genchem (Changzhou) Co., Ltd., located in 658 Yulong Road N., Binjiang Industrial park, Xinbei, Changzhou, Jiangsu Province. At present, we have formed a unique product chain from R&D, production to..
Relevance: 24.28408
  • astantetherapeutics.com
  • 1
  • 2
At Astante Therapeutics we develop drugs with novel mechanisms of action that are enhanced by drug efflux. Our unique drug delivery strategy co-opts drug efflux for therapeutic benefit by linking an anti-cancer immune response, from bystander immune..
Relevance: 23.243958
  • trilotherapeutics.com
  • 1
  • 9
Our fully synthetic Trilomers® use 100% mirror-image D-amino acids, are inherently resistant to proteases at the disease site, and have reduced renal uptake by natural scavenger receptors... We are focused on the discovery of innovative treatments..
Relevance: 23.053503
  • en.protelight.com
  • 1
  • 1
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. was established in April 2009. It is a high-tech biopharmaceutical enterprise focusing on the research, development and production of peptide drugs and chemical drugs. The company is located..
Relevance: 22.95594
  • www.pinotbio.com
  • 1
Pinotbio conducts R&D on an ADC platform, a best-in-class targeted anticancer drug, and a glaucoma medicine... We are a biotech company developing new treatments for patients resistant to existing therapies based on innovative new drug modalities..
Relevance: 22.496727
  • www.metonpharma.com
Zhejiang Meton Pharmaceutical Co., LTD., established in 2020 and based in Hangzhou, China, is dedicated to innovative drug discovery. Benifiting from the long-time research experience of our scientists in cancer metabolism, Meton's current R&D..
Relevance: 22.154207
  • www.detroitrandd.com
  • 4
  • 1
  • 1
Detroit R&D (DRD) is an NIH SBIR-sponsored company that specializes in the development and manufacture of ELISA, antibodies and assay kits for research, diagnosis and treatment of cardiovascular disease and cancer... Detroit R&D, Inc. was founded in..
Relevance: 21.544329
  • www.yuexingyy.com
  • 5
  • 6
Jiangsu Yuexing Pharmaceutical Co., Ltd. is located in Xinghua economic development zone of Jiangsu province. Xinghua is also the hometown of the national most beautiful rape flower, ‘native place of Zhengbanqiao, cradle of Water..
Relevance: 21.102556
  • www.inanod.com
  • 1
  • 1
iNANOD AS is a privately owned start-up company growing through the pull mechanism of innovation from the Oslo Cancer Cluster Incubator. iNANOD utilizes nano-biotechnology to establish a platform to improve drug delivery, especially within oncology...
Relevance: 21.08116
  • allarity.com
  • 6
  • 4
  • 10
At Allarity we leverage our proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Our DRP® technology has been broadly validated across an extensive array of therapies and..
Relevance: 20.963858
  • www.acura-nanomed.com
  • 1
  • 1
Acura Nanomedicine Inc. funded in July 2017. The scientific team of Acura Nanomed. is consist of Ph.Ds & Masters with multi-discipline backgrounds of biotech., medical science, chemical engineering, & nanotechnology. By integrating & applying..
Relevance: 20.929232
  • www.sspacegen.com
  • 1
  • 1
Xiamen SpacegenCo., Ltd., integrating R & D, production, sales and advisory services, is dedicated to providing the most innovative products and services for cancer, genetic diseases and other personalized precision medical testing.We provide the..
Relevance: 20.91029
  • www.myrztech.com
  • 4
  • 1
MyrzTech is a drug delivery company dedicated to the innovation of targeted drug delivery system, using proprietary liposome, nanoparticle, and receptor-targeting technologies as core competencies. Our key business objective is to develop cutting-..
Relevance: 20.848179
  • www.epicsciences.com
  • 4
  • 2
  • 6
For pharmaceutical and clinical investigation partners, our program delivers a bias-free approach for cancer research, to develop clinical solutions that enhance drug development and provide valuable insights into the dynamics of cancer growth and..
Relevance: 20.623117
  • epigenetix.com
  • 1
  • 1
  • 5
Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death... Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis... Guided by..
Relevance: 20.543676
  • allarity.com
  • 6
  • 4
  • 10
So far, Allarity has been able to acquire five drug candidates for our portfolio with terms including low upfront fees, reasonable milestone and royalty payments, and access to existing clinical-grade drug supply. Many of our drug programs come from..
Relevance: 20.508812
  • xiaohonglilab.com
  • 1
  • 1
T he long-term goal of our team is understanding and treating cancer bone metastases, drug resistance, and recurrence. Mechanisms of bone metastases are largely unknown, which impedes the development of new treatments. Our unique strategy is to..
Relevance: 20.445063
  • cgen.com
  • 2
  • 3
  • 23
Compugen is a clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platforms to identify novel drug targets and new biological pathways and develop therapeutics in the field of..
Relevance: 20.431112
  • www.vetcogroup.com
  • 1
  • 1
Vetco Pharmaceuticals is endeavoring to becoming an international pharmaceutical company and penetrate the global market with own branding whether through integrating local medical industry chain, or close collaboration with international..
Relevance: 20.29021
  • ottx.co.uk
Oxford Target Therapeutics (OTT) is a pioneering pharmaceutical company focused on advancing innovative cancer therapies. We specialise in identifying and developing novel drug candidates that target crucial cellular processes involved in cancer..
Relevance: 20.280052
  • cddf.org
  • 1
  • 2
  • 14
For many years, the Cancer Drug Development Forum (CDDF) has focused on developing initiatives that accelerate effective drug development in oncology treatment, reduce time to market, and improve patient access... The CDDF offers workshops,..
Relevance: 20.237537
  • cansar.ai
  • 1
canSAR is public resource, powered by an international collaboration led from University of Texas MD Anderson Cancer Center, in collaboration with the Computational Biology and Chemogenomics team in the CRUK and The Institute of Cancer Research ,..
Relevance: 20.159342
  • www.gcc-ccpf.com
  • 1
  • 1
  • 5
Gulf Coast Consortia (GCC) Center for Comprehensive PK/PD & Formulation (CCPF), funded by Cancer Prevention & Research Institute of Texas (CPRIT), is a state-of-the-art drug development core facility with experienced faculty from Texas Southern..
Relevance: 20.139854
  • senexbio.com
  • 1
  • 1
  • 10
Senex Biotechnology is a drug discovery and development company focused on cancer therapeutics. Senex's lead program targets a protein that regulates gene expression and is required by cancer cells to adapt to adversarial conditions; such adaptation..
Relevance: 20.132753
  • www.wass-michaelislab.org
  • 3
  • 21
We combine wet abd dry lab research primarily in the area of acquired drug resistance in cancer and we also have an interest in studying virus pathogenicity... To systematically study acquired drug resistance in cancer, we have now established the..
Relevance: 20.056267
  • www.wass-michaelislab.org
  • 3
  • 21
To systematically study acquired drug resistance in cancer, we have now established the Resistant Cancer Cell Line (RCCL) collection, a unique collection of 1300 cancer cell lines representing acquired resistance in 15 cancer entities and includes..
Relevance: 20.037998
  • dynxp.com
  • 1
  • 1
  • 10
Dynamix Pharmaceuticals is an innovative cancer and autoimmune drug discovery and development biopharmaceutical company focusing on Kinase inhibitors and Cancer Metabolism... Dynamix is a venture-backed pharmaceutical company focused on the..
Relevance: 19.97303
  • www.crosshairtx.com
  • 2
At Crosshair, we are harnessing the adeno-associated virus (AAV) to deliver our peptides, encoding them as DNA, just as gene therapies are encoded. We then use our D-Chains to modify the surface of the AAV, which enables the AAV to reach a specific..
Relevance: 19.946796
  • www.oncofetal.com
  • 1
Sharma Lab focuses on the triquetra of early development, regeneration, and cancer. We are interested in understanding the developmental origin of cancer by uncovering the similarities between embryogenesis and tumor development. In close association..
Relevance: 19.929827